Theonie Anastassiadis

Fondatore presso Flagship Labs 89, Inc.

Health Technology

Finance

Consumer Services

Profilo

Ms. Theonie Anastassiadis is a Chief Innovation Officer at Alltrna, a President at Prologue Medicines, Inc. and a Principal at Flagship Pioneering.
She received her undergraduate degree from Haverford College.

Posizioni attive di Theonie Anastassiadis

Società	Posizione	Inizio
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Analista di Private Equity	-
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Fondatore	-
Flagship Labs 89, Inc.	Fondatore	-

Tutte le posizioni attive di Theonie Anastassiadis

Formazione di Theonie Anastassiadis

Haverford College

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Theonie Anastassiadis

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	3
Flagship Pioneering Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts.	Finance
Alltrna Alltrna BiotechnologyHealth Technology Alltrna is a biotech company that uses AI/ML tools to learn the language of tRNA and develop programmable molecules with therapeutic potential. Alltrna was founded in 2018 by Flagship Pioneering and is based in Cambridge, MA. The company aims to correct diseases by advancing a single tRNA medicine to treat a wide range of diseases with the same underlying genetic mutation. The company's CEOs are Michelle C. Werner and Lovisa Afzelius.	Health Technology
Flagship Labs 89, Inc.	Health Technology

Vedi le connessioni aziendali